Last 57.95 INR
Change Today +3.35 / 6.14%
Volume 1.7M
As of 7:06 AM 04/21/14 All times are local (Market data is delayed by at least 15 minutes).

orchid chemicals & pharma (OCP) Snapshot

Open
54.90
Previous Close
54.60
Day High
58.60
Day Low
54.35
52 Week High
12/26/13 - 73.20
52 Week Low
08/6/13 - 34.80
Market Cap
4.1B
Average Volume 10 Days
1.1M
EPS TTM
--
Shares Outstanding
70.5M
EX-Date
09/13/12
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for ORCHID CHEMICALS & PHARMA (OCP)

Related News

No related news articles were found.

orchid chemicals & pharma (OCP) Related Businessweek News

No Related Businessweek News Found

orchid chemicals & pharma (OCP) Details

Orchid Chemicals & Pharmaceuticals Limited, an integrated pharmaceutical company, engages in the research development, manufacture, sale, and export of active pharmaceutical ingredients (APIs) and finished dosage forms or formulations in India. Its API product portfolio includes oral cephalosporins, injectable cephalosporins, carbapenems, non-antibiotics, penicillins, and veterinary products. The company also offers anti-infectives, anti-inflammatory, central nervous system, cardio vascular system, nutraceutical, other oral and sterile products, anti-diabetic formulations, neuropsychiatry system formulations. In addition, it provides contract research and manufacturing services. The company has a strategic partnership with Allecra Therapeutics for the development of antibiotics. Orchid Chemicals & Pharmaceuticals Limited was founded in 1992 and is headquartered in Chennai, India.

4,455 Employees
Last Reported Date: 08/27/12
Founded in 1992

orchid chemicals & pharma (OCP) Top Compensated Officers

Chairman, Managing Director, Chairman of Shar...
Total Annual Compensation: 74.2M
Compensation as of Fiscal Year 2013.

orchid chemicals & pharma (OCP) Key Developments

Orchid Chemicals & Pharmaceuticals Limited, Board Meeting, Mar 31, 2014

Orchid Chemicals & Pharmaceuticals Limited, Board Meeting, Mar 31, 2014. Agenda: To consider fixing the accounting period for the financial year 2013-14 for a period of 12 Months from October 01, 2013 to September 30, 2014.

Orchid Chemicals & Pharmaceuticals Limited Appoints K. N. Venkatasubramanian as Non-Executive, Independent Director

Orchid Chemicals & Pharmaceuticals Ltd. has informed that Shri K. N. Venkatasubramanian has been inducted into the board of the company as a Non-Executive, Independent director with effect from March 31, 2014.

Orchid Chemicals & Pharmaceuticals Limited Announces Change in Nominee Director

Orchid Chemicals & Pharmaceuticals Ltd. has announced that Industrial Development Bank of India has withdrawn the nomination of Shri K. Biju George and instead appointed Shri T. A. Ganesh, General Manager, IDBI Bank Ltd, Chennai as its nominee on the Board of the company with effect from March 21, 2014.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
OCP:IN 57.95 INR +3.35

OCP Competitors

Market data is delayed at least 15 minutes.

Company Last Change
CF Industries Holdings Inc $242.34 USD -5.38
Phosagro OAO 1,269 RUB +3.30
Potash Corp of Saskatchewan Inc C$38.45 CAD -0.12
Saudi Arabian Mining Co SR36.10 SAR +0.14
Mosaic Co/The $48.72 USD +0.08
View Industry Companies
 

Industry Analysis

OCP

Industry Average

Valuation OCP Industry Range
Price/Earnings NM Not Meaningful
Price/Sales -- Not Meaningful
Price/Book -- Not Meaningful
Price/Cash Flow NM Not Meaningful
TEV/Sales -- Not Meaningful
 | 

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ORCHID CHEMICALS & PHARMA, please visit www.orchidpharma.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.